NL7314433A - - Google Patents

Info

Publication number
NL7314433A
NL7314433A NL7314433A NL7314433A NL7314433A NL 7314433 A NL7314433 A NL 7314433A NL 7314433 A NL7314433 A NL 7314433A NL 7314433 A NL7314433 A NL 7314433A NL 7314433 A NL7314433 A NL 7314433A
Authority
NL
Netherlands
Application number
NL7314433A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7314433A publication Critical patent/NL7314433A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
NL7314433A 1972-10-25 1973-10-19 NL7314433A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722252157 DE2252157C3 (de) 1972-10-25 1972-10-25 Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten

Publications (1)

Publication Number Publication Date
NL7314433A true NL7314433A (en:Method) 1974-04-29

Family

ID=5859936

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7314433A NL7314433A (en:Method) 1972-10-25 1973-10-19

Country Status (15)

Country Link
US (1) US3883496A (en:Method)
JP (1) JPS528835B2 (en:Method)
AT (1) AT329780B (en:Method)
AU (1) AU6171773A (en:Method)
BE (1) BE806522A (en:Method)
CA (1) CA1011734A (en:Method)
CH (1) CH602597A5 (en:Method)
DD (1) DD109214A5 (en:Method)
DE (1) DE2252157C3 (en:Method)
FR (1) FR2204616B1 (en:Method)
GB (1) GB1453454A (en:Method)
HU (1) HU173215B (en:Method)
IL (1) IL43474A (en:Method)
NL (1) NL7314433A (en:Method)
SE (1) SE7314471L (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32015E (en) * 1974-06-12 1985-10-29 Hoechst Aktiengesellschaft Process for the manufacture of insulin, analogs and derivatives thereof
DE2428412A1 (de) * 1974-06-12 1976-01-15 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DE2439296A1 (de) * 1974-08-16 1976-02-26 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US4659006A (en) * 1985-09-26 1987-04-21 Rca Corporation Method of bonding a die to a substrate
DE3880346T2 (de) * 1987-02-25 1993-07-29 Novonordisk As Insulinderivate.
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
EP0428849A3 (en) * 1989-09-28 1991-07-31 Hoechst Aktiengesellschaft Retroviral protease inhibitors
US5646242A (en) * 1994-11-17 1997-07-08 Eli Lilly And Company Selective acylation of epsilon-amino groups
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
US8618049B2 (en) 2009-09-08 2013-12-31 Stephen B. H. Kent Ester insulin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH77A (de) * 1889-01-09 Christian Herren Wurzelschneidmaschine
IE36225B1 (en) * 1971-01-28 1976-09-15 Nat Res Dev Improvements relating to insulin derivatives

Also Published As

Publication number Publication date
HU173215B (hu) 1979-03-28
AU6171773A (en) 1975-04-24
ATA901073A (de) 1975-08-15
FR2204616B1 (en:Method) 1978-10-27
AT329780B (de) 1976-05-25
DD109214A5 (en:Method) 1974-10-20
US3883496A (en) 1975-05-13
FR2204616A1 (en:Method) 1974-05-24
JPS528835B2 (en:Method) 1977-03-11
GB1453454A (en) 1976-10-20
BE806522A (fr) 1974-04-25
IL43474A0 (en) 1974-01-14
CH602597A5 (en:Method) 1978-07-31
DE2252157A1 (de) 1974-05-09
DE2252157B2 (de) 1975-07-24
CA1011734A (en) 1977-06-07
SE7314471L (en:Method) 1974-04-26
DE2252157C3 (de) 1976-03-18
IL43474A (en) 1978-01-31
JPS4980090A (en:Method) 1974-08-02

Similar Documents

Publication Publication Date Title
CS161817B2 (en:Method)
JPS4992992A (en:Method)
JPS528835B2 (en:Method)
CS162953B1 (en:Method)
FR2199406A6 (en:Method)
JPS4910471A (en:Method)
CS158170B2 (en:Method)
JPS5710021B2 (en:Method)
JPS4940141A (en:Method)
JPS5336472Y2 (en:Method)
JPS4880328A (en:Method)
JPS48106644U (en:Method)
CS154090B1 (en:Method)
CS162140B1 (en:Method)
CS159803B1 (en:Method)
JPS49100655A (en:Method)
JPS4955289U (en:Method)
CS161367B1 (en:Method)
CH575128A5 (en:Method)
CH599224A5 (en:Method)
CH588722A5 (en:Method)
CH563039A5 (en:Method)
CH571031A5 (en:Method)
CH589079A5 (en:Method)
CH571105B5 (en:Method)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed